Product Images Lacosamide

Lacosamide Injection, USP is a medication that is only for Intravenous Use. It comes in 10 x 20 mL Single-Dose Vials, with each vial containing 20 mL solution for infusion. The single-dose vial of 20 mL contains 200 mg lacosamide. The drug is manufactured by Aspiro Pharma Limited and Sold by XLCare Pharmaceuticals, Inc. The USUAL DOSAGE information is available in the package insert. It should be stored at 20° to 25°C (68° to 77°R); excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. There's a Medication Guide available at the website mentioned in the last line of the text.*

This is a graph showing a seizure reduction of 21% for placebo and different doses of Lacosamide per day (200, 400, 600) over a period of 6 months. Statistically significant differences were observed between Lacosamide and placebo groups.*

This is a table showing responder rates, improvements, and worsening for patients in different groups taking placebo or different doses of lacosamide. The percentage of patients is also indicated.*

This is a medication label for Lacosamide Injection, USP, manufactured by Aspiro Pharma Limited in India for XLCare Pharmaceuticals, Inc. The label provides information about dosage, storage, and manufacturing details, including the batch code and license number. It also includes a warning to keep the medication out of reach of children and a website where a medication guide is available. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). A US contact number is also provided.*